Maurice McDonald Heiner1. 1. Wesley Medical Centre, Auchenflower, Queensland, Australia. lyn.sellars@wesley.com.au <sellars@wesley.com.au>
Abstract
OBJECTIVE: Despite recent advances in asthma treatment, its management in many patients remains sub-optimal. The aim of the Global Asthma Physicians and Patient (GAPP) survey was to identify barriers to optimal asthma management and to explore the content and dynamics of physician-patient communications. Here we present the key findings for adults with asthma in Australia. RESEARCH DESIGN AND METHODS: Patients with asthma aged > or = 18 years and physicians who treat adults (generalists; specialists) participated in telephone interviews conducted in May-June 2005, using close-end questionnaires. The survey examined physicians' beliefs and prescribing habits; patients' experiences with asthma; doctor-patient communication; satisfaction with asthma medications and interest in new asthma treatment. RESULTS: A total of 101 adults with asthma and 100 physicians treating asthma patients in Australia completed the survey. Overall, key barriers to optimal asthma management included medication side effects, treatment compliance and patient education. These barriers may be exacerbated by poor patient-physician communication that fails to address patients concerns regarding side effects and may lead to poor treatment compliance. Both physicians and patients expressed safety concerns regarding the long-term use of inhaled corticosteroid and both groups would welcome new treatment options with improved safety profiles, efficacy and once-daily dosing. CONCLUSION: From both a physician and patient perspective, the safety profile of asthma medication constitutes a key factor in promoting treatment compliance and, ultimately, treatment outcomes. The results highlight discrepancies in perceived patient-physician communication and a need for improved patient education in asthma management.
OBJECTIVE: Despite recent advances in asthma treatment, its management in many patients remains sub-optimal. The aim of the Global Asthma Physicians and Patient (GAPP) survey was to identify barriers to optimal asthma management and to explore the content and dynamics of physician-patient communications. Here we present the key findings for adults with asthma in Australia. RESEARCH DESIGN AND METHODS: Patients with asthma aged > or = 18 years and physicians who treat adults (generalists; specialists) participated in telephone interviews conducted in May-June 2005, using close-end questionnaires. The survey examined physicians' beliefs and prescribing habits; patients' experiences with asthma; doctor-patient communication; satisfaction with asthma medications and interest in new asthma treatment. RESULTS: A total of 101 adults with asthma and 100 physicians treating asthmapatients in Australia completed the survey. Overall, key barriers to optimal asthma management included medication side effects, treatment compliance and patient education. These barriers may be exacerbated by poor patient-physician communication that fails to address patients concerns regarding side effects and may lead to poor treatment compliance. Both physicians and patients expressed safety concerns regarding the long-term use of inhaled corticosteroid and both groups would welcome new treatment options with improved safety profiles, efficacy and once-daily dosing. CONCLUSION: From both a physician and patient perspective, the safety profile of asthma medication constitutes a key factor in promoting treatment compliance and, ultimately, treatment outcomes. The results highlight discrepancies in perceived patient-physician communication and a need for improved patient education in asthma management.
Authors: Eleanor C Majellano; Vanessa L Clark; Rebecca F McLoughlin; Peter G Gibson; Vanessa M McDonald Journal: PLoS One Date: 2022-06-07 Impact factor: 3.752
Authors: Job F M van Boven; Jaap C A Trappenburg; Thys van der Molen; Niels H Chavannes Journal: NPJ Prim Care Respir Med Date: 2015-07-16 Impact factor: 2.871
Authors: Nikki Newhouse; Angela Martin; Sena Jawad; Ly-Mee Yu; Mina Davoudianfar; Louise Locock; Sue Ziebland; John Powell Journal: BMJ Open Date: 2016-12-28 Impact factor: 2.692
Authors: Michael S Blaiss; Michael A Kaliner; Carlos E Baena-Cagnani; Ronald Dahl; Erkka J Valovirta; Giorgio W Canonica Journal: World Allergy Organ J Date: 2009-12 Impact factor: 4.084
Authors: Astrid Crespo-Lessmann; Vicente Plaza; Francisco-Javier González-Barcala; Toni Fernández-Sánchez; Joaquín Sastre Journal: BMJ Open Respir Res Date: 2017-09-13